American Heart Journal
Volume 152, Issue 4 , Pages 641-647 , October 2006

Prevalence, predictors, and outcomes of patients with non–ST-segment elevation myocardial infarction and insignificant coronary artery disease: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative

  • Manesh R. Patel, MD

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • Corresponding Author InformationReprint requests: Manesh R. Patel, MD, PO Box 17969, Duke Clinical Research Institute, Durham, NC 27705.
    • ,
  • Anita Y. Chen, MS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Eric D. Peterson, MD, MPH

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • L. Kristin Newby, MD, MHS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Charles V. Pollack Jr., MD, MA

      Affiliations

    • Pennsylvania Hospital, University of Pennsylvania School of Medicine, Philadelphia, PA
    • ,
  • Ralph G. Brindis, MD, MPH

      Affiliations

    • San Francisco Kaiser Permanente Hospital, San Francisco, CA
    • ,
  • C. Michael Gibson, MD

      Affiliations

    • Harvard Clinical Research Institute, Boston, MA
    • ,
  • Neal S. Kleiman, MD

      Affiliations

    • Section of Cardiology, Baylor College of Medicine, Oklahoma City, OK
    • ,
  • Jorge F. Saucedo, MD

      Affiliations

    • University of Oklahoma Health Sciences Center, Oklahoma City, OK
    • ,
  • Deepak L. Bhatt, MD

      Affiliations

    • Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH
    • ,
  • W. Brian Gibler, MD

      Affiliations

    • University of Cincinnati School of Medicine, Cincinnati, OH
    • ,
  • E. Magnus Ohman, MD

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Robert A. Harrington, MD

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Matthew T. Roe, MD, MHS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC

Received 17 June 2005 ,Accepted 5 February 2006.

References 

  1. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365–372
  2. Yamagishi M, Terashima M, Awano K, et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol. 2000;35:106–111
  3. Maehara A, Mintz GS, Bui AB, et al. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol. 2002;40:904–910
  4. Saito T, Date H, Taniguchi I, et al. Angiographic evaluation of culprit lesions in acute coronary syndrome: relation to the original site on previous coronary angiography. Jpn Circ J. 1998;62:359–363
  5. Roe MT, Harrington RA, Prosper DM, et al. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease. The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation. 2000;102:1101–1106
  6. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2000;36:970–1062
  7. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22
  8. Papanicolaou MN, Califf RM, Hlatky MA, et al. Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries. Am J Cardiol. 1986;58:1181–1187
  9. Pecora MJ, Roubin GS, Cobbs BW, et al. Presentation and late outcome of myocardial infarction in the absence of angiographically significant coronary artery disease. Am J Cardiol. 1988;62:363–367
  10. Diver DJ, Bier JD, Ferreira PE, et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol. 1994;74:531–537
  11. Kontos MC, Fritz LM, Anderson FP, et al. Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J. 2003;146:446–452
  12. White HD. Things ain't what they used to be: impact of a new definition of myocardial infarction. Am Heart J. 2002;144:933–937
  13. Antman EM. Troponin measurements in ischemic heart disease: more than just a black and white picture. J Am Coll Cardiol. 2001;38:987–990
  14. Kontos MC, Shah R, Fritz LM, et al. Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. J Am Coll Cardiol. 2004;43:958–965
  15. Wang CH, Kuo LT, Hung MJ, et al. Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease. Am Heart J. 2002;144:275–281
  16. Harding MB, Leithe ME, Mark DB, et al. Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal's variant angina. J Am Coll Cardiol. 1992;20:107–111
  17. Panteghini M. Role and importance of biochemical markers in clinical cardiology. Eur Heart J. 2004;25:1187–1196
  18. Wong GC, Morrow DA, Murphy S, et al. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat angina with Aggrastat and determine cost of therapy with an invasive or conservative strategy—thrombolysis in myocardial infarction. Circulation. 2002;106:202–207
  19. Kurisu S, Sato H, Kawagoe T, et al. Tako-tsubo–like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J. 2002;143:448–455
  20. Kurisu S, Inoue I, Kawagoe T, et al. Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo–like left ventricular dysfunction. J Am Coll Cardiol. 2003;41:743–748
  21. Girod JP, Messerli AW, Zidar F, et al. Images in cardiovascular medicine. Tako-tsubo–like transient left ventricular dysfunction. Circulation. 2003;107:e120–e121
  22. Reis SE, Holubkov R, Conrad Smith AJ, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J. 2001;141:735–741
  23. Johnson BD, Shaw LJ, Buchthal SD, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary artery disease: results from the National Institutes of Health-National Heart, Lung, Blood Institute–sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109:2993–2999
  24. Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA. 2005;293:477–484

 CRUSADE is a national quality improvement initiative of the Duke Clinical Research Institute. CRUSADE is funded by the Schering-Plough Corporation, Kenilworth, NJ. Bristol-Myers Squibb, New York, NY/Sanofi-Aventis Pharmaceuticals, Paris, France. Partnership provides additional funding support. Millennium Pharmaceuticals, Inc., Cambridge, MA, also funded this work.

PII: S0002-8703(06)00254-7

doi: 10.1016/j.ahj.2006.02.035

American Heart Journal
Volume 152, Issue 4 , Pages 641-647 , October 2006

Article Tools